Early detection and management of major non-communicable diseases in urban primary healthcare facilities in Ethiopia: a study protocol for a type-3 hybrid implementation-effectiveness design.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
04 01 2021
Historique:
entrez: 5 1 2021
pubmed: 6 1 2021
medline: 15 5 2021
Statut: epublish

Résumé

Integrating early detection and management of non-communicable diseases in primary healthcare has an unprecedented role in making healthcare more accessible particularly in low- and middle-income countries such as Ethiopia. This study aims to design, implement and evaluate an evidence-based intervention guided by the HEARTS technical package and implementation guide to address barriers and facilitators of integrating early detection and management of hypertension, diabetes mellitus and cardiovascular diseases in primary healthcare settings of Addis Ababa. We will employ a type-3 hybrid implementation-effectiveness study from November 2020 to May 2022. This study will target patients ≥40 years of age. Ten health centres will be randomly selected from each subcity of Addis Ababa. The study will have four phases: (1) Baseline situational analysis (PEN facility-capacity assessment, 150 observations of patient healthcare provider interactions and 697 patient medical record reviews), (2) Consolidated Framework for Implementation Research (CFIR) inspired qualitative assessment of barriers and facilitators (20 in-depth interviews of key stakeholders), (3) Design of intervention protocol. The intervention will have capacity enhancement components including training of non-communicabledisease (NCDservice providers, provision of essential equipment/supporting materials and monthly monitoring and feedback and (4) Implementation monitoring and evaluation phase using the RE-AIM (reach, efficacy, adoption, implementation and maintenance) framework. Outcomes on early detection and management of NCDs will be assessed to examine the effectiveness of the study. Ethical clearance was obtained from the Addis Ababa University, College of Health Sciences Institutional Review Board and Addis Ababa Health Bureau. We plan to present the findings from this research in conferences and publish them in peer-reviewed journals.

Identifiants

pubmed: 33397663
pii: bmjopen-2020-040564
doi: 10.1136/bmjopen-2020-040564
pmc: PMC7783522
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e040564

Subventions

Organisme : Medical Research Council
ID : MR/M025470/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Lancet. 2010 Nov 20;376(9754):1785-97
pubmed: 21074253
Lancet. 2010 Nov 27;376(9755):1861-8
pubmed: 21074258
Learn Health Syst. 2019 Sep 26;4(1):e10201
pubmed: 31989028
BMJ. 2019 Jan 28;364:l327
pubmed: 30692118
Lancet. 2018 Sep 22;392(10152):1072-1088
pubmed: 30264707
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Indian J Community Med. 2011 Dec;36(Suppl 1):S67-71
pubmed: 22628915
BMC Health Serv Res. 2018 May 31;18(1):395
pubmed: 29855306
Bull World Health Organ. 2019 Feb 1;97(2):142-153
pubmed: 30728620
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Glob Heart. 2014 Dec;9(4):431-43
pubmed: 25592798
Western Pac Surveill Response J. 2015 Nov 06;6 Suppl 1:21-4
pubmed: 26767130
BMC Res Notes. 2019 Feb 14;12(1):87
pubmed: 30764864

Auteurs

Helen Yifter (H)

Department of Internal Medicine, Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia.

Afrah Omer (A)

Department of Public Health Nutrition and Dietetics, Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia afrahsanni@gmail.com.
Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.

Seid Gugsa (S)

Department of Internal Medicine, Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia.

Abebaw Fekadu (A)

Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.

Abraham Kebede (A)

School of Health Sciences, University of Brighton, Brighton, UK.

Tewodros Gebremariam (T)

Department of Internal Medicine, Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia.

Addisu Melkie (A)

Department of Internal Medicine, Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia.

Negussie Deyessa (N)

Department of Epidemiology and Biostatistics, Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH